Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AME Study of PA-824 in Healthy Men
NCT03202693Phase 1Completed
- Sponsor
- TB Alliance
- Start
- Mar 2006
- Primary completion
- May 2006
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of pretomanid in Tuberculosis (TB), sponsored by TB Alliance. Primary endpoints: Area Under the Curve, Maximum Concentration and 1 more. Started Mar 2006; status: completed.
02
Drugs
pretomanid
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT03202693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03202693.